New‐onset left bundle branch block‐associated idiopathic nonischemic cardiomyopathy and time from diagnosis to cardiac resynchronization therapy: The NEOLITH II study

Background The optimal timing for cardiac resynchronization therapy (CRT) after diagnosis of new‐onset left bundle branch block (LBBB)‐associated idiopathic nonischemic cardiomyopathy (NICM) and treatment with guideline‐directed medical therapy (GDMT) is unknown. The purpose of this study was to des...

Full description

Saved in:
Bibliographic Details
Published inPacing and clinical electrophysiology Vol. 41; no. 2; pp. 143 - 154
Main Authors Wang, Norman C., Li, Jack Z., Adelstein, Evan C., Althouse, Andrew D., Sharbaugh, Michael S., Jain, Sandeep K., Mendenhall, G. Stuart, Shalaby, Alaa A., Voigt, Andrew H., Saba, Samir
Format Journal Article
LanguageEnglish
Published United States Wiley Subscription Services, Inc 01.02.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background The optimal timing for cardiac resynchronization therapy (CRT) after diagnosis of new‐onset left bundle branch block (LBBB)‐associated idiopathic nonischemic cardiomyopathy (NICM) and treatment with guideline‐directed medical therapy (GDMT) is unknown. The purpose of this study was to describe relationships between time from diagnosis to CRT and outcomes in new‐onset LBBB‐associated idiopathic NICM with left ventricular ejection fraction (LVEF) ≤35%. Methods A retrospective cohort study examined associations between time from diagnosis to CRT (≤9 months vs >9 months) and clinical and echocardiographic outcomes. Results In 123 subjects with LBBB‐associated idiopathic NICM, time from diagnosis to CRT was ≤9 months in 60 (49%) subjects and 9 months in 63 (51%) subjects. Clinical outcomes were similar for those implanted ≤9 months versus >9 months for adverse clinical events (hazard ratio [HR], 0.85; 95% confidence interval [CI], 0.41–1.78; P = 0.67) and all‐cause mortality (HR, 0.57; 95% CI, 0.19–1.70; P = 0.31). Multivariable analyses demonstrated similar results. In 105 subjects with post‐CRT echocardiograms, LVEF improvement to >35% was more likely in those implanted ≤9 months when compared to >9 months (odds ratio [OR], 3.53; 95% CI, 1.32–9.46; P = 0.01). This association persisted in the final multivariable model adjusted for age at diagnosis, sex, QRS duration, post‐GDMT LVEF, and time from CRT to post‐CRT echocardiogram (OR, 5.10; 95% CI, 1.71–15.22; P = 0.004). Conclusion In LBBB‐associated idiopathic NICM, earlier CRT implantation was associated with more favorable cardiac remodeling. Delaying CRT may miss a critical period to halt and reverse progressive myocardial damage.
Bibliography:Author Disclosures
:
Dr. Wang has received research support from Boston Scientific and fellowship support from Abbott and Medtronic. Dr. Adelstein has received research support from Abbott and Medtronic. Dr. Jain has received research support from Medtronic. Dr. Mendenhall has received consulting/speaker honoraria and research support from Medtronic. Dr. Saba serves as an unpaid consultant for and has received research support from Abbott, Boston Scientific, and Medtronic.
Funding
This research did not receive any specific grant from funding agencies in the public, commercial, or not‐for‐profit sectors.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0147-8389
1540-8159
1540-8159
DOI:10.1111/pace.13264